Diebold Nixdorf, Incorporated DBD
59.36 USD +1.12 (+1.92%)
Nov 9, 2026, 10:06 AM EST
59.17 Day range 60.03
52.87 52-week range 92.09
- YTD
- -12.56%
- 1 year
- -7.97%
DBD revenue history
Revenue is income from the company’s ordinary business activities.
3,805,700,000 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 3,805,700,000 | 54,600,000 | 1.46% |
| FY 2024 | 2024-12-31 | 3,751,100,000 | Not available | Not available |
| FY 2022 | 2022-12-31 | 3,460,700,000 | -444,500,000 | -11.38% |
| FY 2021 | 2021-12-31 | 3,905,200,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-10-31T06:00:33.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.